<DOC>
	<DOCNO>NCT00707057</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety multiple dos Ibuprofen 600 mg Extended-Release Tablets study dental pain follow extraction third molar teeth .</brief_summary>
	<brief_title>Ibuprofen Extended-Release Dental Pain Study</brief_title>
	<detailed_description>This single-center , multiple-dose , randomize , placebo-controlled , double-blinded , parallel group trial evaluate efficacy safety multiple dos Ibuprofen 600 mg Extended-Release Tablets study dental pain follow extraction third molar teeth . The surgery consist surgical extraction 1-2 impacted third molar , one must mandibular impaction partially impact either tissue bone . Subjects stratify accord baseline pain intensity , rat 11-point pain intensity numerical rating scale ( PI-NRS ) gender .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Toothache</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Males females 16 45 year age ; Outpatients schedule undergo surgical extraction 12 impacted third molar ( ) , one must mandibular impaction partially impact either tissue bone ; At least score 5 11point pain intensity numerical rating scale ( PINRS ) baseline ; Use follow preoperative medication ( ) / anesthetic ( ) : shortacting local anesthetic ( e.g. , mepivacaine lidocaine ) without vasoconstrictor and/or nitrous oxide ; Reliable , cooperative , adequate intelligence record request information analgesic questionnaire form ; Subjects ( parent legal guardian subject age 18 year ) require read , comprehend , sign inform consent . Subjects require parent legal guardian sign inform consent require sign assent ; Examined attend dentist physician medically clear participate study ; , In general good health contraindication study med . Presence serious medical condition ( e.g. , poorly control hypertension , poorly control diabetes , significantly impaired cardiac , renal hepatic function , hyper hypothyroidism ) ; Use prescription nonprescription drug administration ibuprofen , celecoxib , nonsteroidal antiinflammatory drug ( NSAID ) , acetaminophen , contraindicate ; Acute local infection time surgery could confound postsurgical evaluation ; Females pregnant , lactate , childbearing potential , postmenopausal less 2 year use medically approve method contraception ( i.e. , oral , transdermal , implanted contraceptive , intrauterine device , diaphragm , condom , abstinence , surgical sterility ) , females test positive urinebased pregnancy test ; Presence history ( within 2 year enrollment ) bleed disorder ( ) peptic ulcer disease ; Presence history ( within past year ) alcoholism substance abuse . Subjects take CNS psychotropic drug ( include St. John 's Wort , nutritional supplement know psychotropic effect ) may enrol stable dos medication least 2 month , maintain dose throughout study , condition judge Principal Investigator wellcontrolled ; Habituation analgesic drug ( i.e. , routine use oral analgesic 5 time per week ) ; History allergic reaction ( eg , asthma , rhinitis , swell , shock , hive ) ibuprofen , naproxen , aspirin , celecoxib , NSAID , acetaminophen ; Prior use type analgesic NSAID 5 halflives drug less take first dose study medication , except preanesthetic medication anesthesia procedure ; Ingestion caffeinecontaining beverage , chocolate , alcohol 4 hour less take first dose study medication ; Has take investigational product within past 30 day ; Has previously enter study ; , The subject member study site staff either directly involved study , employee Sponsor , relative study site personnel directly involve study Sponsor .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>